1. Home
  2. PRPL vs PMVP Comparison

PRPL vs PMVP Comparison

Compare PRPL & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$0.33

Market Cap

76.9M

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.20

Market Cap

66.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
PMVP
Founded
2010
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
66.1M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
PRPL
PMVP
Price
$0.33
$1.20
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$0.65
N/A
AVG Volume (30 Days)
251.6K
277.5K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
152.75
N/A
EPS
N/A
N/A
Revenue
$468,725,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$6.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$1.02
52 Week High
$1.26
$1.88

Technical Indicators

Market Signals
Indicator
PRPL
PMVP
Relative Strength Index (RSI) 30.59 52.80
Support Level N/A $1.13
Resistance Level $0.44 $1.26
Average True Range (ATR) 0.03 0.07
MACD -0.00 0.01
Stochastic Oscillator 19.53 58.60

Price Performance

Historical Comparison
PRPL
PMVP

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: